What is the CVSS score of CVE-2021-45031?

CVE-2021-45031 has a CVSS 3.1 base score of 7.7 (High). CVSS vector: CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:L/A:H. EPSS exploitation probability: 0.4%.

Stawiz Usc CVE-2021-45031

HIGH

Authentication Bypass by Primary Weakness (CWE-305)

2022-03-30 iletisim@usom.gov.tr

Information Disclosure Stawiz Usc

7.7

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

7.7 HIGH

AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:L/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:L/A:H

Attack Vector

Network

Attack Complexity

High

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

Low

Availability

High

Lifecycle Timeline

CVE Published

Mar 30, 2022 - 20:15 cve.org

HIGH 7.7

DescriptionCVE.org

A vulnerability in MEPSAN's USC+ before version 3.0 has a weakness in login function which lets attackers to generate high privileged accounts passwords.

AnalysisAI

A vulnerability in MEPSAN's USC+ before version 3.0 has a weakness in login function which lets attackers to generate high privileged accounts passwords. Rated high severity (CVSS 7.7), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-305. A vulnerability in MEPSAN's USC+ before version 3.0 has a weakness in login function which lets attackers to generate high privileged accounts passwords. Affected products include: Mepsan Stawiz Usc\+\+. Version information: version 3.0.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.